Viridian Therapeutics (VRDN) had the highest return on March 30 by a mid-cap US stock, returning 9%.

ASSET	DATE	% RETURN
Viridian Therapeutics (VRDN)	3/30/2026	9%
Bath & Body Works (BBWI)	3/30/2026	8.17%
VinFast Auto Ltd Ordinary Shares (VFS)	3/30/2026	6.18%
Utz Brands (UTZ)	3/30/2026	5.53%
Guardian Pharmacy Services (GRDN)	3/30/2026	5.52%
Morningstar (MORN)	3/30/2026	5.01%
Casella Waste Systems (CWST)	3/30/2026	4.42%
GeneDx (WGS)	3/30/2026	4.41%
Baldwin Insurance (BWIN)	3/30/2026	4.36%
Clear Secure (YOU)	3/30/2026	4.01%
Vericel Corp Ord (VCEL)	3/30/2026	3.98%
Trade Desk (TTD)	3/30/2026	3.82%
Skyward Specialty Insurance Group, Inc Common Stock (SKWD)	3/30/2026	3.72%
ManpowerGroup (MAN)	3/30/2026	3.7%
Netskope, Inc Class A Common Stock (NTSK)	3/30/2026	3.61%
Calumet Specialty Products Partners (CLMT)	3/30/2026	3.58%
Amplitude (AMPL)	3/30/2026	3.5%
Bright Horizons Family Solutions (BFAM)	3/30/2026	3.36%
Adaptive Biotechnologies (ADPT)	3/30/2026	3.21%
HCI (HCI)	3/30/2026	3.18%
Ideaya Biosciences (IDYA)	3/30/2026	3.15%
Grupo Aval (AVAL)	3/30/2026	3.15%
Axsome Therapeutics (AXSM)	3/30/2026	3.13%
Hamilton Lane (HLNE)	3/30/2026	3.1%
NIQ Global Intelligence (NIQ)	3/30/2026	3.07%

Mid-cap stocks are treated as having a market cap between $2B and $10B.